Showing results (551-560 of 744) with videos related to

Sort By:
Pageof 75
Antimicrobial Agents and Chemotherapy|December 1, 1991
Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infectionC Flexner, P A Barditch-Crovo, D M Kornhauser, et al.
American Journal of Respiratory and Critical Care Medicine|May 30, 2014
Impact of GeneXpert MTB/RIF on patients and tuberculosis programs in a low-burden setting. a hypothetical trialJ Lucian Davis, L Masae Kawamura, Lelia H Chaisson, et al.
AIDS (London, England)|February 13, 2023
Viral suppression among adults with HIV receiving routine dolutegravir-based antiretroviral therapy and 3 months weekly isoniazid-rifapentineLelia H Chaisson, Fred C Semitala, Florence Nangobi, et al.
Drugs|December 29, 2024
Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art ReviewViolet Chihota, Makaita Gombe, Amita Gupta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 18, 2015
Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis PreventionAnthony T Podany, Yajing Bao, Susan Swindells, et al.
JAMA|March 16, 1990
Projections of AIDS morbidity and mortality in San FranciscoG F Lemp, S F Payne, G W Rutherford, et al.
Clinical Immunology (Orlando, Fla.)|May 18, 2019
Cis-regulatory genetic variants in the CCR5 gene and natural HIV-1 control in black South AfricansGemma W Koor, Maria Paximadis, Anabela C P Picton, et al.
The American Journal of Managed Care|June 18, 2020
Value-based insurance design in Louisiana: Blue Cross Blue Shield's Zero Dollar Co-pay programXiaojing Yuan, Janet Chaisson, Dawn Cantrell, et al.
American Journal of Respiratory and Critical Care Medicine|May 6, 2006
Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosisWilliam J Burman, Stefan Goldberg, John L Johnson, et al.
AIDS (London, England)|November 17, 2010
The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) studyBetina Durovni, Solange C Cavalcante, Valeria Saraceni, et al.
Pageof 75